Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 325 | 969 | 1,000 | 971 | 880 |
| Cost of Goods | N/A | 87 | 113 | 93 | -1,660 |
| Gross Profit | 619 | 882 | 887 | 877 | -1,350 |
| Operating Expenses | 2,888 | 2,901 | 2,522 | 2,284 | 690 |
| Operating Income | -2,562 | -1,932 | -1,522 | -1,314 | 1,190 |
| Interest Expense | 0 | 0 | 0 | 0 | 10 |
| Other Income | 266 | 225 | 350 | 351 | -3,480 |
| Pre-tax Income | -2,296 | -1,707 | -1,172 | -963 | -2,300 |
| Net Income Continuous | -2,296 | -1,707 | -1,172 | -963 | -1,336 |
| Net Income Discontinuous | 609 | 3,198 | -25 | -158 | -256 |
| Net Income | $-1,687 | $1,491 | $-1,197 | $-1,121 | $-1,592 |
| EPS Basic Total Ops | -5.60 | 5.60 | -4.80 | -4.80 | -6.40 |
| EPS Basic Continuous Ops | -8.80 | -6.40 | -4.80 | -4.00 | -5.37 |
| EPS Basic Discontinuous Ops | 2.41 | 12.62 | -0.10 | -0.63 | -1.03 |
| EPS Diluted Total Ops | -5.60 | 5.60 | -4.80 | -4.80 | -6.40 |
| EPS Diluted Continuous Ops | -8.80 | -6.40 | -4.80 | -4.00 | -5.37 |
| EPS Diluted Discontinuous Ops | 2.42 | 12.60 | -0.10 | -0.63 | -1.03 |
| EBITDA(a) | $-2,437 | $-1,689 | $-1,522 | $-1,314 | $1,190 |